Disease | cholangitis |
Symptom | C0022346|jaundice |
Sentences | 13 |
PubMedID- 24212634 | In the cholecystojejunostomy group, a recurrence of jaundice with consecutive cholangitis occurred in up to 10% of cases, whereas this was not seen in the hepaticojejunostomy group, but the difference was not significant . |
PubMedID- 24212633 | An extensive review and a randomized controlled trial both showed that choledochojejunostomy, though technically more difficult, has higher success rates to relieve obstructive jaundice and lower rates of recurrent jaundice and cholangitis, compared with cholecystojejunostomy . |
PubMedID- 22741140 | We report here on a case of obstructive jaundice with acute cholangitis that was caused by an impacted pancreatic stone in the papilla in a patient with chronic pancreatitis. |
PubMedID- 26140095 | Patients with cca typically present with obstructive jaundice, and associated complications of cca include cholangitis and biliary sepsis. |
PubMedID- 26064830 | In summary, we have described a case of ascending cholangitis with obstructive jaundice secondary to food material impacted in the cbd through a cdf. |
PubMedID- 21286351 | The patient presented with cholestatic jaundice and picture of sclerosing cholangitis in endoscopic retrograde cholangiography. |
PubMedID- 23024865 | Choledocholithiasis may develop as a complication and manifest as obstructive jaundice with or without cholangitis . |
PubMedID- 25649526 | Patient selection bias (obstructive jaundice with cholangitis in initial treatment, chemotherapy before surgical resection, stent diameter, stent length, among others) could not rule out in this retrospective study. |
PubMedID- 22873816 | Occlusion of the stent was considered if patients had recurrent jaundice with cholestasis or cholangitis (fever, increase in serum bilirubin, leucocytosis) and dilatation of intrahepatic bile duct, revealed by imaging. |
PubMedID- 23898377 | The indications for steroid therapy in aip published in the japanese consensus guidelines for the management of aip22 include symptoms such as obstructive jaundice due to associated sclerosing cholangitis, and symptomatic extrapancreatic lesions such as hydronephrosis due to retroperitoneal fibrosis. |
PubMedID- 22548071 | In the japanese consensus guidelines for the management of aip , indications for steroid therapy in aip include symptoms such as obstructive jaundice due to associated sclerosing cholangitis and the presence of symptomatic extrapancreatic lesions such as hydronephrosis due to retroperitoneal fibrosis. |
PubMedID- 20423779 | A small group of patients who have undergone a ry-hta develop cholangitis without jaundice, with proven permeability of the anastomosis. |
PubMedID- 24604946 | frank biliary rupture occurs in 3-17%; biliary obstruction and cholangitis leads to jaundice, fever and chills. |
Page: 1